Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
644 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2023-05-31 | 2023-10-03 | 193436 |
| MYLAN-RIVASTIGMINE PATCH 10 | 9.5MG | PATCH | Resolved | 2024-03-25 | 2024-04-16 | 223273 |
| MYLAN-NITRO PATCH 0.8 | 82.9MG | PATCH (EXTENDED RELEASE) | Avoided shortage | 2017-03-23 | 2017-03-29 | 4080 |
| MYLAN-NITRO PATCH 0.6 | 62.2MG | PATCH (EXTENDED RELEASE) | Avoided shortage | 2017-03-23 | 2017-12-20 | 4086 |
| MYLAN-NITRO PATCH 0.8 | 82.9MG | PATCH (EXTENDED RELEASE) | Resolved | 2017-04-20 | 2017-06-16 | 7417 |
| MYLAN-NITRO PATCH 0.2 | 20.7MG | PATCH (EXTENDED RELEASE) | Resolved | 2017-05-26 | 2017-10-19 | 11406 |
| MYLAN-NITRO PATCH 0.4 | 41.4MG | PATCH (EXTENDED RELEASE) | Resolved | 2017-07-18 | 2017-08-16 | 16239 |
| WIXELA INHUB | 50MCG 500MCG | POWDER | Resolved | 2022-03-11 | 2022-03-16 | 156586 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Resolved | 2017-10-10 | 2018-06-08 | 24841 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2017-11-20 | 2018-06-08 | 29772 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2017-11-20 | 2018-06-08 | 29777 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-05-12 | 2020-05-26 | 114859 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-06-03 | 2020-06-17 | 116453 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130641 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-03-10 | 2017-03-14 | 226 |
| PYRIDOXINE HYDROCHLORIDE INJECTION, USP | 100MG | SOLUTION | Resolved | 2017-03-10 | 2018-08-07 | 238 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2017-03-23 | 2017-05-03 | 4083 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2017-03-24 | 2018-10-20 | 4133 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6979 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-04-13 | 2022-01-12 | 6982 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55130 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |